Long-term efficacy but rare sustained remission: Individual-level five-year stability in anti-IL5/R&#x3b1; biologic therapy response for severe asthma

RECOMMENDED

Asthma

Long-Term Clinical Remission on Benralizumab Treatment in Severe Eosinophilic Asthma: A Four-Year Real-Life Study

★ 2 Recommended by Dr Martin Frey, Faculty Member

★ 2 Recommended by Dr Marcus Hesse, Faculty Member

J Clin Med

Quarato CMI, Tondo P, Lacedonia D, Soccio P, Pescatore D, Baccellieri ML, Lepore G, Foschino Barbaro MP, Scioscia G

doi: 10.3390/jcm14062075

COMMENTED

Asthma

The role of bronchial biopsy in the prediction of response to biological therapy in severe uncontrolled asthma: a prospective study

★ 3 Recommended and commented by Dr Martin Frey, Faculty Member

★ 2 Recommended by Dr Marcus Hesse, Faculty Member

Chest

Cosío BG, Iglesias A, Shafiek H, Mosteiro M, Escribano I, Toledo-Pons N, Valera JL, Bellvert CG, Pérez de Llano L

doi: 10.1016/j.chest.2024.11.045

AsthmaRespiratory Tract Infection

Clinical response and remission in patients treated with dupilumab for severe asthma: Results from the nationwide Danish Severe Asthma Register

Respir Med

Hansen S, Håkansson KEJ, Soendergaard MB, Bjerrum AS, Schmid JM, Johansson SL, Rasmussen LM, Johnsen CR, von Bülow A, Bonnesen B, Krogh NS, Hilberg O, Dongo L, Vijdea R, Ulrik CS, Porsbjerg C

doi: 10.1016/j.rmed.2025.108203

COMMENTED

Asthma

Secondary Non-Response to Biologic Treatment in Patients with Severe Asthma

★ 2 Recommended by Dr Martin Frey, Faculty Member

★ 3 Recommended and commented by Dr Marcus Hesse, Faculty Member

J Asthma Allergy

Mobayed H, Al-Nesf M, Ibrahim T, Aqel S, Al-Ahmad M, Bousquet J

doi: 10.2147/JAA.S517784

RECOMMENDED

AsthmaRespiratory Tract Infection

Efficacy Assessment of Biological Treatments in Severe Asthma

★ 1 Recommended by Dr Martin Frey, Faculty Member

★ 3 Recommended by Dr Marcus Hesse, Faculty Member

J Clin Med

Laorden D, Domínguez-Ortega J, Romero D, Villamañán E, Mariscal-Aguilar P, Granda P, Quirce S, Álvarez-Sala R, On Behalf Of Asmagrave-Hulp Group

doi: 10.3390/jcm14020321

COMMENTED

Asthma

XALOC-1: Clinical remission over 2-years with benralizumab in severe eosinophilic asthma

★ 3 Recommended and commented by Dr Marcus Hesse, Faculty Member

Chest

Pelaia G, Jackson DJ, Nair P, Emmanuel B, Tran TN, Menzies-Gow A, Watt M, Kayaniyil S, Boarino S, Nuevo J, Pardal M, Shavit A, Shih VH, Cohen D, Loureiro C, Padilla-Galo A

doi: 10.1016/j.chest.2025.04.011

COMMENTED

Asthma

Biologic Therapy in Severe Asthma: A Phenotype-Driven and Targeted Approach

★ 1 Recommended by Dr Martin Frey, Faculty Member

★ 3 Recommended and commented by Dr Marcus Hesse, Faculty Member

J Clin Med

D'Amato M, Pastore D, Lupia C, Candia C, Bruni A, Garofalo E, Longhini F, Maglio A, Petrone A, Vatrella A, Pelaia G, Pelaia C

doi: 10.3390/jcm14134749

RECOMMENDED

Asthma

Early and Sustained Response to Benralizumab in Severe, Eosinophilic Asthma: A Real-World Observational Study

★ 2 Recommended by Dr Martin Frey, Faculty Member

★ 3 Recommended by Dr Marcus Hesse, Faculty Member

J Asthma Allergy

Stolz D, Schuoler C, Charbonnier F, Bridevaux PO, Jandus P, Leuppi JD, Pavlov N, Piecyk A, Rothe T

doi: 10.2147/JAA.S495867

RECOMMENDED

COPD

Real-World Efficacy of BDP/FF/G Fixed Triple Inhalation Powder (NEXThaler) Therapy in the Treatment of Moderate to Severe COPD patients (RESPONSE Study)

★ 2 Recommended by Dr Martin Frey, Faculty Member

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

Respir Med

Dulai V, Keglevich A, Sánta B, Abonyi-Tóth Z, Horváth I

doi: 10.1016/j.rmed.2025.108498

Pneumology

Long-term efficacy but rare sustained remission: Individual-level five-year stability in anti-IL5/Rα biologic therapy response for severe asthma

Related content

Long-Term Clinical Remission on Benralizumab Treatment in Severe Eosinophilic Asthma: A Four-Year Real-Life Study

The role of bronchial biopsy in the prediction of response to biological therapy in severe uncontrolled asthma: a prospective study

Clinical response and remission in patients treated with dupilumab for severe asthma: Results from the nationwide Danish Severe Asthma Register

Secondary Non-Response to Biologic Treatment in Patients with Severe Asthma

Efficacy Assessment of Biological Treatments in Severe Asthma

XALOC-1: Clinical remission over 2-years with benralizumab in severe eosinophilic asthma

Biologic Therapy in Severe Asthma: A Phenotype-Driven and Targeted Approach

Early and Sustained Response to Benralizumab in Severe, Eosinophilic Asthma: A Real-World Observational Study

Real-World Efficacy of BDP/FF/G Fixed Triple Inhalation Powder (NEXThaler) Therapy in the Treatment of Moderate to Severe COPD patients (RESPONSE Study)